Ladenburg Thalmann Initiates Coverage On Peak Bio With Buy Rating, Announces Price Target of $15
Ladenburg Thalmann Initiates Coverage On Peak Bio With Buy Rating, Announces Price Target of $15
拉登堡塔爾曼以買入評級啓動對Peak Bio的報道，宣佈目標股價爲15美元
Ladenburg Thalmann analyst Ahu Demir initiates coverage on Peak Bio (NASDAQ:PKBO) with a Buy rating and announces Price Target of $15.
拉登堡·塔爾曼分析師阿胡·德米爾以買入評級開始對Peak Bio（納斯達克股票代碼：PKBO）進行報道，並宣佈目標股價爲15美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。